Potential Neuroprotective Effects Emerging research suggests GLP-1s may have neuroprotective properties, potentially lowering the risk of neurodegenerative conditions such as Alzheimers and Parkinsons disease
Hathaway JT, Shah MP, Hathway DB, et al
May 16, 2025: More than 1,800 Active Lawsuits in Group Lawsuit for People Harmed by Ozempic As of May, there are 1,809 active lawsuits in the MDL representing people harmed by Ozempic and other GLP-1 drugs
Stopping the medication comes with changes in food cravings and increased hunger, leading to changes in weight, with some people experiencing weight gain
The human brain drives everything we do, from how we move to how we feel and think